Tue.Nov 26, 2024

article thumbnail

Novartis plots more than 100 layoffs in New Jersey as part of rework to Xolair, cancer combo field sales teams

Fierce Pharma

While Novartis has largely wrapped up its transformation into a leaner innovative medicines company—which included multiple rounds of staff cuts over the years—employment changes are still afoot at | Novartis is laying off a total of 139 staffers in East Hanover, New Jersey, where the company’s U.S. headquarters is located. The move will primarily affect commercial field sales associates working on the brands Xolair for asthma and allergies and the oncology combo made up of kinase inhibitors Taf

Sales 269
article thumbnail

Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition

MedCity News

Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The post Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition appeared first on MedCity News.

Biopharma 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower

Fierce Pharma

German CDMO Adragos Pharma has been on a growth tear this year, drafting plans to boost capacity in Japan, upgrading a facility in France, taking over another from Fresenius Kabi in Norway and more | German CDMO Adragos Pharma has been on a growth tear this year. Now, the manufacturing arriviste—which was founded in 2020—is expanding its production network again with the acquisition of Switzerland's Baccinex, which specializes in fill and finish services.

article thumbnail

GLP-1 receptor agonists aid broader outcomes in kidney disease, major analysis finds

European Pharmaceutical Review

Glucagon-like peptide-1 (GLP-1) receptor agonists have shown to provide meaningful benefits in chronic kidney disease (CKD) and individuals with and without diabetes. This based on the largest, most comprehensive analysis of GLP-1 antagonists on kidney and cardiovascular outcomes. While GLP-1 receptor agonists have shown benefit for type 2 diabetes, obesity and cardiovascular disease, its impact as a treatment in chronic kidney disease is not as clear, the researchers explained.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Shorla gains FDA nod for first oral liquid version of Novartis' Gleevec

Fierce Pharma

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.

FDA 184
article thumbnail

MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding

MedCity News

In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the company recently received through the Sprint for Women’s Health program. The post MedCity FemFwd: How Celmatix is Using ARPA-H’s Sprint for Women’s Health Funding appeared first on MedCity News.

More Trending

article thumbnail

Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator

MedCity News

Amgen’s experimental obesity drug, MariTide, led to an average 20% reduction in weight in a Phase 2 clinical trial. While investors hoped for greater weight loss, some analysts say less burdensome monthly dosing of MariTide could make it competitive against weekly injectable weight drugs Zepbound and Wegovy. The post Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator appeared first on MedCity News.

article thumbnail

MSD adds rocket fuel to Winrevair's engine in PAH

pharmaphorum

ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch.

article thumbnail

HRSA Commits $52M to Health Centers Supporting People Leaving Incarceration

MedCity News

The Health Resources and Services Administration is making a $52 million investment in 54 health centers to support the health needs of those leaving incarceration. The post HRSA Commits $52M to Health Centers Supporting People Leaving Incarceration appeared first on MedCity News.

93
article thumbnail

Medigene axes staff and refocuses its TCR pipeline

pharmaphorum

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline.

Leads 85
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care

MedCity News

Pricy GLP-1 medications are here to stay — let’s focus on turning their potential into lasting, meaningful impact. The post The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care appeared first on MedCity News.

Medical 88
article thumbnail

How the incoming administration could impact FTC’s approach to M&A scrutiny

PharmaVoice

Pharma companies looking to get a break from the FTC under a new administration may be out of luck.

Pharma 87
article thumbnail

How 3 Health Systems Are Scaling Hybrid & Home-Based Models

MedCity News

Leaders from three health systems — Providence, OSF HealthCare and UMass Memorial Health — detailed how their organizations are maximizing hybrid and home-based care models during a recent panel. The post How 3 Health Systems Are Scaling Hybrid & Home-Based Models appeared first on MedCity News.

article thumbnail

Biden ramps up Medicare coverage of obesity drugs

pharmaphorum

Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, but will the plan see the light of day?

64
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

AI-Powered Insights for Personalized Customer Experiences: The Art of Data-Driven Engagement

MedCity News

While advanced analytics and AI can unlock unprecedented insights, it’s the thoughtful application of these insights that transforms routine interactions between pharmaceutical representatives and healthcare providers into lasting relationships. The post AI-Powered Insights for Personalized Customer Experiences: The Art of Data-Driven Engagement appeared first on MedCity News.

article thumbnail

Roche buys off-the-shelf CAR-T player Poseida for $1bn

pharmaphorum

Roche has upgraded its partnership with off-the-shelf CAR-T therapy specialist Poseida to a $1 billion-plus takeover bid.

71
article thumbnail

ACO Leadership Summit Returns to Dallas, Addressing Healthcare’s Most Pressing Challenges

PM360

The highly anticipated ACO Leadership Summit is set to take place on March 17-18, 2025, at The Ritz-Carlton Dallas, Las Colinas. This invitation-only premium forum will bring together senior executives from both public and private healthcare sectors to address transformative strategies in value-based care delivery and contracting. The 2025 summit arrives at a crucial time as healthcare organizations navigate complex challenges in care delivery, digital transformation, and payment models.

article thumbnail

Biohaven’s Taldefgrobep Alfa Fails to Achieve Statistical Significance in Treating Spinal Muscular Atrophy

PharmExec

Results of the RESILIENT SMA study found that while taldefgrobep demonstrated clinically meaningful motor function improvements in patients with spinal muscular atrophy, the treatment arm did not achieve statistical significance at 48 weeks.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

CAR-T therapies: Faster, better, cheaper

pharmaphorum

Tune in to this podcast episode featuring an interview with Phil Johnson from Interius Biotherapeutics as he discusses the latest advancements in CAR-T therapies, focusing on faster, better, and cheaper treatments.

52
article thumbnail

Ethical Considerations for AI Use in Healthcare Marketing

Eversana Intouch

The Current Landscape: AI’s Transformative Impact on Healthcare Marketing The healthcare marketing industry is at the forefront of a significant transformation, driven by advances in artificial intelligence (AI). Today, generative AI applications – particularly large language models (LLMs) and image-generation tools – are streamlining labor-intensive tasks such as research, documentation, content editing and concept ideation.

Ethics 52
article thumbnail

Do Wearable Health Devices Improve Patient Health?

Referral MD

Wearable fitness devices have become famous for tracking physical health and empowering individuals to participate actively in their well-being. With today’s advanced technology, these devices can monitor everything from heart rate and blood pressure to glucose levels, offering real-time insights into personal health metrics. In the broader landscape of medical technology, the Digital Front Door is the gateway for patients to seamlessly connect with their healthcare providers for scheduling, com

article thumbnail

How Leaders Can Foster Proactive and Reactive Change

Pharmaceutical Commerce

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, offers advice for effectively being able to adjust plans.

Pharma 52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Pharmaceutical Technology Excellence Awards 2024: PCI Pharma Services 

Pharmaceutical Technology

PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology Excellence Awards.

article thumbnail

KinetiSol® Technology: Disrupting the Solid Amorphous Dispersion Landscape

PharmaTech

Elizabeth Hickman (Chief Business Officer, AustinPx) explains the company's approach to improving bioavailability, highlighting KinetiSol technology.

52
article thumbnail

Children’s Hospital of Philadelphia Announces New Imaging AI Technology

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Roche’s tiragolumab flops in another Phase III lung cancer trial

Pharmaceutical Technology

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the anti-TIGIT therapy.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Pharma Pulse 11/26/24: RFID Technological Obstacles, Self-Care for the Flu & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond

PharmaVoice

Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.

article thumbnail

Shorla Oncology’s IMKELDI approved by FDA for leukaemia cancers

Pharmaceutical Technology

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer forms.

article thumbnail

Collaborative Health Care: The Essential Role of Pharmacists in Multidisciplinary Teams

Pharmacy Times

Pharmacists play a vital role in multidisciplinary health care teams by enhancing medication safety, optimizing therapeutic outcomes, expanding medication access, reducing costs, and improving patient education.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A